Atea Pharmaceuticals, Inc.
AVIR
$3.08
$0.0150.49%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.85% | -32.60% | -65.80% | -49.73% | -17.30% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -0.48% | 16.53% | 60.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.55% | 3.90% | -3.12% | -13.82% | -17.63% |
| Change in Net Operating Assets | -146.25% | -3.73% | 203.19% | 256.13% | 134.69% |
| Cash from Operations | -58.67% | -49.15% | -36.88% | -3.91% | 29.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.21% | 89.58% | 139.42% | 116.93% | 108.89% |
| Cash from Investing | 39.21% | 89.58% | 139.42% | 116.85% | 108.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.89% | 3.89% | -22.44% | -22.44% | -30.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.89% | 3.89% | -22.44% | -22.44% | -30.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.48% | -1.53% | 106.26% | 95.68% | 92.22% |
